C-peptide is not a simple laboratory test
DOI:
https://doi.org/10.15277/bjd.2021.312Keywords:
C-peptide, Diabetes, TherapeuticReferences
Pinger CW, Entwistle K, Bell TM, Liu Y, Spence DM. C-peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment? Mol Biosyst 2017;13(8):1432–7. https://doi.org/10.1039/C7MB00199A
Danne T, Kordonouri O. Use of technology to potentially preserve C-peptide in type 1 diabetes mellitus. Pediatr Endocrinol Rev 2010;7(Suppl 3):396–400.
Morrison AE, Sim SY, Kong M-F, Gregory R. Type 1 or type 2 diabetes: has the ship already sailed? Br J Diabetes 2021;21:116–9. https://doi.org/10.15277/bjd.2021.297
Washburn RL, Mueller K, Kaur G, et al. C-peptide as a therapy for type 1 diabetes mellitus. Biomedicines 2021;9(3):270. https://doi.org/10.3390/biomedicines9030270
Abdel-Hamid HA, Abdel-Hakeem EA, Zenhom NM, Toni N. C-peptide corrects hepatocellular dysfunction in a rat model of type 1 diabetes. J Physiol Biochem 2020;76(3):417–25. https://doi.org/10.1007/s13105-020-00748-y
Published
Issue
Section
License
Manuscripts published in the June 2024 edition and after in the BJD have been published in open access under a Creative Commons Attribution 4.0 International License and available at https://www.bjd-abcd.com. Prior year articles are available free of charge via our website.